Modeling dose-response in amblyopia: Toward a child-specific treatment plan

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 6, 2007, Pages 2589-2594

  Stewart, Catherine E ^a   Stephens, David A ^b,c   Fielder, Alistair R ^a   Moseley, Merrick J ^a  

^a CITY UNIVERSITY   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMBLYOPIA; ANISOMETROPIA; ARTICLE; CHILD; CONTROLLED STUDY; EYE REFRACTION; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; MONITOR; PRIORITY JOURNAL; STRABISMUS; THERAPY EFFECT; TREATMENT PLANNING; TREATMENT RESPONSE; VISUAL ACUITY; LIGHT; PHYSIOLOGY; PRESCHOOL CHILD; RADIATION RESPONSE; SENSORY DEPRIVATION; THEORETICAL MODEL;

AMBLYOPIA; ANISOMETROPIA; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LIGHT; MODELS, THEORETICAL; SENSORY DEPRIVATION; STRABISMUS; VISUAL ACUITY;

EID: 34347257819     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-1243     Document Type: Article

References (28)

1. Daw NW. Critical periods and amblyopia. Arch Ophthalmol. 1998;116:502-505.
2. Daw NW. Mechanisms of plasticity in the visual cortex. Invest Ophthalmol Vis Sci. 1994;35:4168-4179.
3. Hall DMB, Elliman D, eds. Health for all Children. 4th ed. Oxford, UK: Oxford University Press; 2003:230-344.
4. Hartman EE, Dobson V, Hainline L et al. Preschool vision screening: summary of a task force report. Ophthalmology. 2001;108:479-486.
5. Park KH, Hwang JM, Ahn JK. Efficacy of amblyopia therapy initiated after 9 years of age. Eye. 2004;18:571-574.
6. Mohan K, Saroha V, Sharma A. Successful occlusion therapy for amblyopia in 11- to 15-year old children. J Pediatr Ophthalmol Strabismus. 2004;41:89-95.
7. The Pediatric Eye Disease Investigator Group. A prospective pilot study of treatment of amblyopia in children 10 to 18 years old. Am J Ophthalmol. 2004;137:581-583.
8. Stewart CE, Moseley MJ, Stephens DA, Fielder AR, and the MOTAS cooperative. The treatment dose-response in amblyopia therapy: results from the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci. 2004;45:3048-3054.
9. The Pediatric Eye Disease Investigator Group. A randomized trial of patching regimens for treatment of moderate amblyopia in children. Arch Ophthalmol. 2003;121:603-611.
10. The Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology. 2003;110:2075-2087.
11. Clarke MP, Wright CM, Hrisos S, Anderson JD, Henderson J, Richardson SR. Randomised controlled trial of treatment of unilateral visual impairment detected at preschool vision screening. BMJ. 2003;327:1251-1256.
12. The Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children. Arch Ophthalmol. 2002;120:268-278.
13. Awan M, Proudlock FA, Gottlob I. A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance. Invest Ophthalmol Vis Sci. 2005;46:1435-1439.
14. Fleck BW. Amblyopia therapy: more evidence that we need evidence. Br J Ophthalmol. 2003;87:255-256.
15. Stewart CE, Fielder AR, Stephens DA, Moseley MJ, MOTAS Cooperative. Treatment of unilateral amblyopia: factors influencing visual outcome. Invest Ophthalmol Vis Sci. 2005;46:3152-3160.
16. Stewart CE, Fielder AR, Stephens DA, Moseley MJ. Design of the Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Br J Ophthalmol. 2002;86:915-919.
17. Moseley MJ, Neufield M, McCarry B, et al. Remediation of refractive amblyopia by optical correction alone. Ophthalmic Physiol Opt. 2002;22:296-299.
18. Fielder AR, Auld R, Irwin M, Cocker KD, Jones HS, Moseley MJ. Compliance monitoring in amblyopia therapy. Lancet. 1994;343:547.
19. http://www.math.mcgill.ca/~dstephens/Papers/MOTAS/. Accessed March 25, 2007.
20. Ruppert D, Wand MP, Carroll RJ. Semiparametric Regression. Cambridge, UK: Cambridge University Press; 2003.
21. Ngo L, Wand MP. Smoothing with mixed model software. J Stat Software. 2004;9:1-5.
22. Massie H. Fixing eye for occlusion: survey of 1,000 cases of patients receiving occlusion of the fixing eye. Trans Ophthalmol Soc Aust. 1965;24:39-46.
23. Lea HSJ, Rubenstein JLMP. The sensitive period for anisometropic amblyopia. Eye. 1989;3:783-790.
24. Kutschke PJ, Scott WE, Keech RV. Anisometropic amblyopia. Ophthalmology. 1991;98:259-263.
25. Cobb CJ, Russell K, Cox A, MacEwan CJ. Factors Influencing visual outcome in anisometropic amblyopes. Br J Ophthalmol. 2002;86:1278-1281.
26. Hiscox FN, Strong N, Thompson JR, Minshull C, Woodruff G. Occlusion for amblyopia: a comprehensive survey of outcome. Eye. 1992;6:300-304.
27. Flynn JT, Woodruff G, Thompson JR, et al. The therapy of amblyopia: an analysis comparing the results of amblyopia therapy utilizing two pooled sets. Trans Am Ophthalmol Soc. 1999;97:373-390.
28. Fulton AB, Mayer DL. Esotropic children with amblyopia: effects of patching on acuity. Graefes Arch Clin Exp Ophthalmol. 1988;226:309-312.